Olmesartan Medoxomil Tablet 40mg (Olmesartan Medoxomil)

Adult dose

The recommended initial dosage is 10mg once a day, administered regardless of meals. If blood pressure control is not sufficient, increase to 20mg once daily. The maximum dosage can be increased up to 40mg once daily. Elderly patients (65 years and older) do not require dosage adjustments. For patients with mild to moderate renal impairment, the maximum dosage is restricted to 20mg once daily. Patients with mild hepatic impairment do not require dosage adjustments.

Child dose

The safety and efficacy of this drug in pediatric patients have not been established, and dosing is not recommended.

This medicine can cause serious harm or death to the fetus and newborn if taken during the second and third trimesters of pregnancy; therefore, it should be discontinued immediately upon confirmation of pregnancy. People who are allergic to this medicine or its ingredients, pregnant or nursing women, patients undergoing renal dialysis, those with severe liver impairment, biliary obstruction, and lactose intolerance should not use this medication. Patients with low blood volume or salt may experience hypotension upon initial use; thus, their condition should be closely monitored, and appropriate treatment should be implemented if hypotension occurs. Patients with impaired kidney function or those who have undergone kidney transplantation should regularly check kidney function and serum potassium levels through blood tests, and use of this drug is not recommended in severe renal impairment. Patients with renal artery stenosis, those at risk for hyperkalemia, and certain heart disease patients need to take extra caution when taking this medication. This drug can cause dizziness, so care should be taken when driving or operating dangerous machinery. During treatment, attention should be paid to avoid combinations with potassium-sparing diuretics or potassium supplements, certain analgesics, lithium, etc., and blood pressure, kidney function, and electrolyte levels should be monitored regularly. It should be avoided during pregnancy to prevent serious fetal anomalies, and in nursing mothers, the decision to use this drug should be made cautiously. The safety of this drug in children has not been established, and for the elderly, adjustments in dosage and monitoring are necessary due to the potential for increased drug levels in the body. In case of overdose, symptoms such as hypotension or palpitations may occur, so seek immediate medical attention for appropriate treatment. This drug is known to have a low risk of carcinogenicity or genotoxicity even with long-term use; however, if any abnormal symptoms occur during use, consultation with a professional should be sought immediately.

Serious side effects

• Hives
• severe swelling (including angioedema)
• chest pain
• chest tightness
• difficulty breathing
• cold sweats
• paleness
• severe rash with fever
• blistering
• skin peeling

Mild side effects

• Dizziness
• headache
• palpitations
• back pain
• itching
• cough
• abdominal pain
• indigestion
• gastroenteritis
• nausea

This medication should be stored in a sealed container to protect it from air or moisture, and it is recommended to keep it at room temperature between 1 degree and 25 degrees Celsius. Proper storage in suitable temperature and container can maintain the effectiveness and safety of the drug.

Appearance

White rectangular film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle